Endothelial glycocalyx integrity of the sublingual microvessels as a predictor of left ventricular performance following STEMI: a 12-month study
Event: ESC Congress 2025
Topic: Microcirculation, Angiogenesis, Arteriogenesis
Session: Innovations in cardiovascular repair: immune, genetic, and therapeutic perspectives
Twelve-month treatment with glucagon-like peptide-1 receptor agonists or sodium-glucose co-transporter-2 inhibitors improves arterial function and myocardial deformation after ischemic stroke
Event: ESC Congress 2025
Topic: Pharmacotherapy
Session: Aortic, peripheral vascular, and cerebrovascular diseases
Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on arterial stiffness, coronary flow reserve and liver steatosis in diabetes
Event: ESC Congress 2024
Topic: Metabolic Syndrome, Insulin, Insulin Resistance
Session: Diabetes: a risk factor in heart disease
The effect of the combined treatment with dulaglutide and dapagliflozin in arterial elasticity, cardiac function, albuminuria and endothelial thickness in type 2 diabetes mellitus after 12 months
Event: ESC Congress 2024
Topic: Renal Failure and Cardiovascular Disease
Session: Coronary artery disease in kidney patients: from genes to treatment
Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after Covid-19 infection are partially improved at twelve months.
Event: EACVI 2023
Topic: Tissue Doppler, Speckle Tracking and Strain Imaging
Session: Increasing the quality of health care delivery and outcomes by multi-modality imaging
